Charles River Laboratories International (CRL) Competitors $154.16 -5.58 (-3.49%) As of 12:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRL vs. ICLR, TECH, IQV, MTD, WAT, ILMN, BIO, BRKR, PACB, and HBIOShould you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include ICON (ICLR), Bio-Techne (TECH), IQVIA (IQV), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), and Harvard Bioscience (HBIO). Charles River Laboratories International vs. Its Competitors ICON Bio-Techne IQVIA Mettler-Toledo International Waters Illumina Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Icon (NASDAQ:ICLR) and Charles River Laboratories International (NYSE:CRL) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, risk, earnings, valuation and institutional ownership. Do insiders & institutionals have more ownership in ICLR or CRL? 95.6% of Icon shares are held by institutional investors. Comparatively, 98.9% of Charles River Laboratories International shares are held by institutional investors. 44.0% of Icon shares are held by insiders. Comparatively, 1.3% of Charles River Laboratories International shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts prefer ICLR or CRL? Icon presently has a consensus target price of $216.67, suggesting a potential upside of 23.24%. Charles River Laboratories International has a consensus target price of $177.07, suggesting a potential upside of 13.64%. Given Icon's stronger consensus rating and higher possible upside, research analysts plainly believe Icon is more favorable than Charles River Laboratories International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Icon 0 Sell rating(s) 7 Hold rating(s) 9 Buy rating(s) 3 Strong Buy rating(s) 2.79Charles River Laboratories International 1 Sell rating(s) 9 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.31 Which has preferable earnings & valuation, ICLR or CRL? Icon has higher revenue and earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIcon$8.28B1.71$791.47M$9.7218.09Charles River Laboratories International$4.05B1.89$22.20M-$1.33-117.16 Which has more risk and volatility, ICLR or CRL? Icon has a beta of 1.2, suggesting that its stock price is 20% more volatile than the S&P 500. Comparatively, Charles River Laboratories International has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Is ICLR or CRL more profitable? Icon has a net margin of 9.82% compared to Charles River Laboratories International's net margin of -1.69%. Charles River Laboratories International's return on equity of 15.74% beat Icon's return on equity.Company Net Margins Return on Equity Return on Assets Icon9.82% 10.95% 6.23% Charles River Laboratories International -1.69%15.74%7.09% Does the media prefer ICLR or CRL? In the previous week, Icon had 5 more articles in the media than Charles River Laboratories International. MarketBeat recorded 16 mentions for Icon and 11 mentions for Charles River Laboratories International. Charles River Laboratories International's average media sentiment score of 1.33 beat Icon's score of 0.12 indicating that Charles River Laboratories International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 2 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Charles River Laboratories International 8 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryIcon beats Charles River Laboratories International on 11 of the 17 factors compared between the two stocks. Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRL vs. The Competition Export to ExcelMetricCharles River Laboratories InternationalMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$7.67B$7.62B$5.80B$21.52BDividend YieldN/A2.82%5.69%3.53%P/E Ratio-117.1574.0274.7329.72Price / Sales1.8944.29470.3452.02Price / Cash7.0623.6037.0824.51Price / Book2.307.4012.254.59Net Income$22.20M$238.91M$3.28B$999.91M7 Day Performance-4.99%2.59%1.39%0.80%1 Month Performance2.05%3.16%7.70%4.80%1 Year Performance-19.81%19.16%64.01%16.06% Charles River Laboratories International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRLCharles River Laboratories International4.5881 of 5 stars$154.17-3.5%$177.07+14.9%-17.5%$7.59B$4.05B-115.9120,100Positive NewsAnalyst UpgradeICLRICON4.0972 of 5 stars$177.81+1.7%$219.64+23.5%-39.6%$14.12B$8.28B18.2941,900Analyst DowngradeTECHBio-Techne4.9902 of 5 stars$54.11-0.6%$70.42+30.1%-27.6%$8.53B$1.22B117.633,100Positive NewsIQVIQVIA4.9413 of 5 stars$187.72+0.0%$229.86+22.4%-19.7%$31.91B$15.41B27.1788,000Positive NewsAnalyst UpgradeMTDMettler-Toledo International4.3033 of 5 stars$1,314.38+0.7%$1,311.11-0.2%-7.8%$26.90B$3.87B33.2817,300Positive NewsWATWaters4.8102 of 5 stars$309.58+1.1%$378.73+22.3%-7.3%$18.23B$2.96B27.927,600ILMNIllumina4.845 of 5 stars$98.18-0.8%$123.06+25.3%-20.4%$15.21B$4.37B12.439,030Positive NewsBIOBio-Rad Laboratories4.623 of 5 stars$290.32-1.7%$333.50+14.9%-10.4%$8.00B$2.57B24.757,700Positive NewsBRKRBruker4.9686 of 5 stars$30.80-0.1%$51.30+66.6%-49.9%$4.68B$3.37B59.2311,396Short Interest ↑PACBPacific Biosciences of California2.7478 of 5 stars$1.25-1.6%$1.90+52.0%-25.0%$381.47M$154.01M-0.55730Positive NewsHBIOHarvard Bioscience3.9751 of 5 stars$0.45-4.9%$3.00+559.9%-84.3%$21.30M$94.14M0.00490Analyst ForecastShort Interest ↑ Related Companies and Tools Related Companies ICON Alternatives Bio-Techne Alternatives IQVIA Alternatives Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CRL) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredNVDA: The cracks are beginning to showThe media hasn't caught up to the story yet, but when they do, this stock could leave Nvidia in the dust. I...InvestorPlace | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
